Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Organicell Regenerative Medicine Inc (OP: OCEL ) 2.750 UNCHANGED Last Price Updated: 3:51 PM EST, Mar 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 2.750 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 2.750 Today's Range 2.750 - 2.750 52wk Range 0.0051 - 3.540 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News RETRANSMISSION: Organicell Regenerative Medicine Rebranding to ZEO ScientifiX March 07, 2024 Via ACCESSWIRE Organicell Announces 1-for-200 Reverse Stock Split November 27, 2023 Via ACCESSWIRE Performance YTD +169.61% +169.61% 1 Month N/A N/A 3 Month N/A N/A 6 Month N/A N/A 1 Year +28545.83% +28545.83% More News Read More Organicell Reports Interim Results of Phase 1/2A Research Program July 26, 2023 Via ACCESSWIRE 1847 Holdings And 3 Other Stocks Under $1 Insiders Are Buying July 12, 2023 Via Benzinga Alset And 2 Other Stocks Under $2 Insiders Are Aggressively Buying July 03, 2023 Via Benzinga Organicell Starts Enrolling Long COVID Trial November 17, 2022 Via ACCESSWIRE Organicell Activates COPD Trial at Mayo Clinic November 15, 2022 Via ACCESSWIRE Organicell Regenerative Medicine, Inc. Announces Additions to Board of Directors October 11, 2022 Via ACCESSWIRE Organicell Regenerative Medicine, Inc. Announces Expansion into Health and Beauty Market September 16, 2022 Via Benzinga Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSO June 29, 2023 Via ACCESSWIRE Organicell Welcomes Harry Leider, MD, MBA as its New CEO June 21, 2023 Via ACCESSWIRE Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses December 27, 2022 Via News Direct Exposures COVID-19 Product Safety Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses December 27, 2022 Via TheNewswire.com Exposures COVID-19 Product Safety Recent Report Shows That Extracellular Vesicles Might Also Be Key To Stopping COVID, Colds, And Other Nasal Viruses December 09, 2022 Via Benzinga Organicell Regenerative Medicine, Inc. Responds to Recent Promotional Activities Pursuant to OTC Markets Request November 21, 2022 Via ACCESSWIRE One in Five Americans Who Have Been Infected With the Virus Said to Have Long COVID November 17, 2022 Via FinancialNewsMedia Exposures COVID-19 Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027 November 15, 2022 Via FinancialNewsMedia Organicell Regenerative Medicine Broadens Access to Valued Business Expertise and Relationship With New Additions to Board of Directors October 13, 2022 Via Benzinga Organicell Regenerative Medicine, Inc. Announces Expansion of Management Team September 20, 2022 Via ACCESSWIRE Pharma Company Organicell Partners With Beauty Health Focusing On Aging & Inflammation Signs September 16, 2022 Via Benzinga Organicell Regenerative Medicine, Inc. Announces Expansion into Health and Beauty Market September 16, 2022 Via ACCESSWIRE BeautyHealth’s Hydrafacial Announces Partnership to Develop Breakthrough Exosome Booster September 14, 2022 From BeautyHealth Via Business Wire Organicell Regenerative Medicine, Inc. Secures Additional $11 Million in Financing in Preparation for Clinical Trial Enrollment September 09, 2022 Via ACCESSWIRE Organicell Regenerative Medicine, Inc. Engages Law Firm McDermott Will & Emery August 30, 2022 Via ACCESSWIRE Organicell Regenerative Medicine, Inc. Closes $5.5 Million Funding Round August 26, 2022 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.